{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:08:32Z","timestamp":1768871312316,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"DOI":"10.7759\/cureus.71771","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:17:58Z","timestamp":1729257478000},"source":"Crossref","is-referenced-by-count":1,"title":["Optimizing Outcomes in Gastrointestinal Stromal Tumors: A Surgeon\u2019s Perspective"],"prefix":"10.7759","author":[{"given":"Mena","family":"Louis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerrell","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2013.01.001","article-title":"Gastrointestinal stromal tumors","volume":"42","author":"Miettinen M","year":"2013","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors. Gastroenterol Clin North Am. 2013, 42:399-415. 10.1016\/j.gtc.2013.01.001","journal-title":"Gastroenterol Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2006.tb00541.x","article-title":"Interstitial cells of Cajal (ICC) and gastrointestinal stromal tumor (GIST): facts, speculations, and myths","volume":"10","author":"Min KW","year":"2006","unstructured":"Min KW, Leabu M. Interstitial cells of Cajal (ICC) and gastrointestinal stromal tumor (GIST): facts, speculations, and myths. J Cell Mol Med. 2006, 10:995-1013. 10.1111\/j.1582-4934.2006.tb00541.x","journal-title":"J Cell Mol Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2006.08.006","article-title":"KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)","volume":"23","author":"Lasota J","year":"2006","unstructured":"Lasota J, Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol. 2006, 23:91-102. 10.1053\/j.semdp.2006.08.006","journal-title":"Semin Diagn Pathol"},{"key":"ref4","article-title":"Gastrointestinal stromal tumors-diagnosis and management: a brief review","volume":"8","author":"Gerrish ST","year":"2008","unstructured":"Gerrish ST, Smith JW. Gastrointestinal stromal tumors-diagnosis and management: a brief review. Ochsner J Winter. 2008, 8:197-204.","journal-title":"Ochsner J Winter"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000494303","article-title":"Clinical presentation of gastrointestinal stromal tumors","volume":"34","author":"Menge F","year":"2018","unstructured":"Menge F, Jakob J, Kasper B, Smakic A, Gaiser T, Hohenberger P. Clinical presentation of gastrointestinal stromal tumors. Visc Med. 2018, 34:335-40. 10.1159\/000494303","journal-title":"Visc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000489556","article-title":"Gastrointestinal stromal tumors: clinical symptoms, location, metastasis formation, and associated malignancies in a single center retrospective study","volume":"36","author":"Aghdassi A","year":"2018","unstructured":"Aghdassi A, Christoph A, Dombrowski F, et al.. Gastrointestinal stromal tumors: clinical symptoms, location, metastasis formation, and associated malignancies in a single center retrospective study. Dig Dis. 2018, 36:337-45. 10.1159\/000489556","journal-title":"Dig Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2018.08.20","article-title":"Gastrointestinal stromal tumors: a comprehensive review","volume":"10","author":"Parab TM","year":"2019","unstructured":"Parab TM, DeRogatis MJ, Boaz AM, et al.. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019, 10:144-54. 10.21037\/jgo.2018.08.20","journal-title":"J Gastrointest Oncol"},{"key":"ref8","article-title":"CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34","volume":"11","author":"Sarlomo-Rikala M","year":"1998","unstructured":"Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol Aug. 1998, 11:728-34.","journal-title":"Mod Pathol Aug"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03624.x","article-title":"DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours","volume":"57","author":"Novelli M","year":"2010","unstructured":"Novelli M, Rossi S, Rodriguez-Justo M, et al.. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology. 2010, 57:259-70. 10.1111\/j.1365-2559.2010.03624.x","journal-title":"Histopathology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2008.06.025","article-title":"Risk stratification of patients diagnosed with gastrointestinal stromal tumor","volume":"39","author":"Joensuu H","year":"2008","unstructured":"Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008, 39:1411-9. 10.1016\/j.humpath.2008.06.025","journal-title":"Hum Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2016.12.001","article-title":"Management of gastrointestinal stromal tumors","volume":"97","author":"Keung EZ","year":"2017","unstructured":"Keung EZ, Raut CP. Management of gastrointestinal stromal tumors. Surg Clin North Am. 2017, 97:437-52. 10.1016\/j.suc.2016.12.001","journal-title":"Surg Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000491649","article-title":"Is the surgical margin in gastrointestinal stromal tumors different?","volume":"34","author":"Rutkowski P","year":"2018","unstructured":"Rutkowski P, Skoczylas J, Wisniewski P. Is the surgical margin in gastrointestinal stromal tumors different?. Visc Med. 2018, 34:347-52. 10.1159\/000491649","journal-title":"Visc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012951","article-title":"Tyrosine kinase inhibitor therapies for gastrointestinal stromal tumours","volume":"2018","author":"Mocellin S","year":"2018","unstructured":"Mocellin S, Pasquali S, Campana L, Yuan Y, Gronchi A, Griffiths E, Vohra R. Tyrosine kinase inhibitor therapies for gastrointestinal stromal tumours. Cochrane Database Syst Rev. 2018, 2018:CD012951. 10.1002\/14651858.CD012951","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-023-01381-6","article-title":"Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours","volume":"26","author":"Naito Y","year":"2023","unstructured":"Naito Y, Nishida T, Doi T. Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours. Gastric Cancer. 2023, 26:339-51. 10.1007\/s10120-023-01381-6","journal-title":"Gastric Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2016.09.15","article-title":"Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review","volume":"8","author":"Oppelt PJ","year":"2017","unstructured":"Oppelt PJ, Hirbe AC, Van Tine BA. Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review. J Gastrointest Oncol. 2017, 8:466-73. 10.21037\/jgo.2016.09.15","journal-title":"J Gastrointest Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880210","article-title":"Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT)","volume":"13","author":"Miettinen M","year":"2000","unstructured":"Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol. 2000, 13:1134-42. 10.1038\/modpathol.3880210","journal-title":"Mod Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e3181d27ec8","article-title":"DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): comparison between 2 different antibodies","volume":"18","author":"Lopes LF","year":"2010","unstructured":"Lopes LF, West RB, Bacchi LM, van de Rijn M, Bacchi CE. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): comparison between 2 different antibodies. Appl Immunohistochem Mol Morphol. 2010, 18:333-7. 10.1097\/PAI.0b013e3181d27ec8","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21037\/tgh.2018.04.01","article-title":"Differential diagnosis of gastrointestinal stromal tumor by histopathology and immunohistochemistry","volume":"3","author":"Hirota S","year":"2018","unstructured":"Hirota S. Differential diagnosis of gastrointestinal stromal tumor by histopathology and immunohistochemistry. Transl Gastroenterol Hepatol. 2018, 3:27. 10.21037\/tgh.2018.04.01","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i10.1238","article-title":"Performance of risk stratification systems for gastrointestinal stromal tumors: a multicenter study","volume":"25","author":"Chen T","year":"2019","unstructured":"Chen T, Ye LY, Feng XY, et al.. Performance of risk stratification systems for gastrointestinal stromal tumors: a multicenter study. World J Gastroenterol. 2019, 25:1238-47. 10.3748\/wjg.v25.i10.1238","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v10.i1.48","article-title":"Comparison between laparoscopic and open surgery for large gastrointestinal stromal tumors: A meta-analysis","volume":"10","author":"Cui JX","year":"2018","unstructured":"Cui JX, Gao YH, Xi HQ, et al.. Comparison between laparoscopic and open surgery for large gastrointestinal stromal tumors: A meta-analysis. World J Gastrointest Oncol. 2018, 10:48-55. 10.4251\/wjgo.v10.i1.48","journal-title":"World J Gastrointest Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.03.007","article-title":"Local recurrence in primary localised resected gastrointestinal stromal tumours:\u00a0a registry observational national cohort study including 912 patients","volume":"186","author":"Bleckman RF","year":"2023","unstructured":"Bleckman RF, Roets E, IJzerman NS, et al.. Local recurrence in primary localised resected gastrointestinal stromal tumours:\u00a0a registry observational national cohort study including 912 patients. Eur J Cancer. 2023, 186:113-21. 10.1016\/j.ejca.2023.03.007","journal-title":"Eur J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.09.60","article-title":"Lymphadenectomy is associated with poor survival in patients with gastrointestinal stromal tumors","volume":"7","author":"Li C","year":"2019","unstructured":"Li C, Su D, Xie C, Chen Q, Zhou J, Wu X. Lymphadenectomy is associated with poor survival in patients with gastrointestinal stromal tumors. Ann Transl Med. 2019, 7:558. 10.21037\/atm.2019.09.60","journal-title":"Ann Transl Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.yasu.2014.05.014","article-title":"Gastrointestinal stromal tumors: who should get imatinib and for how long?","volume":"48","author":"Balachandran VP","year":"2014","unstructured":"Balachandran VP, DeMatteo RP. Gastrointestinal stromal tumors: who should get imatinib and for how long?. Adv Surg. 2014, 48:165-83. 10.1016\/j.yasu.2014.05.014","journal-title":"Adv Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00983.x","article-title":"Imatinib treatment for gastrointestinal stromal tumour (GIST)","volume":"14","author":"Lopes LF","year":"2010","unstructured":"Lopes LF, Bacchi CE. Imatinib treatment for gastrointestinal stromal tumour (GIST). J Cell Mol Med. 2010, 14:42-50. 10.1111\/j.1582-4934.2009.00983.x","journal-title":"J Cell Mol Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.9170","article-title":"Adjuvant imatinib for high-risk GI stromal tumor: analysis of a randomized trial","volume":"34","author":"Joensuu H","year":"2016","unstructured":"Joensuu H, Eriksson M, Sundby Hall K, et al.. Adjuvant imatinib for high-risk GI stromal tumor: analysis of a randomized trial. J Clin Oncol. 2016, 34:244-50. 10.1200\/JCO.2015.62.9170","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108475","article-title":"The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): a lesson from ripretinib","volume":"248","author":"Di Vito A","year":"2023","unstructured":"Di Vito A, Ravegnini G, Gorini F, et al.. The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): a lesson from ripretinib. Pharmacol Ther. 2023, 248:108475. 10.1016\/j.pharmthera.2023.108475","journal-title":"Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3310\/hta13suppl2\/10","article-title":"Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer","volume":"13","author":"Bond M","year":"2009","unstructured":"Bond M, Hoyle M, Moxham T, Napier M, Anderson R. Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer. Health Technol Assess. 2009, 13:69-74. 10.3310\/hta13suppl2\/10","journal-title":"Health Technol Assess"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33630","article-title":"An updated review of the treatment landscape for advanced gastrointestinal stromal tumors","volume":"127","author":"Patel SR","year":"2021","unstructured":"Patel SR, Reichardt P. An updated review of the treatment landscape for advanced gastrointestinal stromal tumors. Cancer. 2021, 127:2187-95. 10.1002\/cncr.33630","journal-title":"Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4103\/sajc.sajc_290_16","article-title":"Metastatic gastrointestinal stromal tumor: a regional cancer center experience of 44 cases","volume":"6","author":"Suresh Babu MC","year":"2017","unstructured":"Suresh Babu MC, Chaudhuri T, Babu KG, et al.. Metastatic gastrointestinal stromal tumor: a regional cancer center experience of 44 cases. South Asian J Cancer. 2017, 6:118-21. 10.4103\/sajc.sajc_290_16","journal-title":"South Asian J Cancer"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21862","article-title":"Surveillance strategies for gastrointestinal stromal tumors","volume":"104","author":"Grotz TE","year":"2011","unstructured":"Grotz TE, Donohue JH. Surveillance strategies for gastrointestinal stromal tumors. J Surg Oncol. 2011, 104:921-7. 10.1002\/jso.21862","journal-title":"J Surg Oncol"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143525","article-title":"Immunotherapy strategies for gastrointestinal stromal tumor","volume":"13","author":"Arshad J","year":"2021","unstructured":"Arshad J, Costa PA, Barreto-Coelho P, Valdes BN, Trent JC. Immunotherapy strategies for gastrointestinal stromal tumor. Cancers (Basel). 2021, 13:3525.","journal-title":"Cancers (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/298375-optimizing-outcomes-in-gastrointestinal-stromal-tumors-a-surgeons-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:18:00Z","timestamp":1729257480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/298375-optimizing-outcomes-in-gastrointestinal-stromal-tumors-a-surgeons-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.71771","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}